Research Article
Nontuberculous Mycobacteria in Guadeloupe, Martinique, and French Guiana from 1994 to 2012
Table 3
Isolation patterns of rarely isolated NTM species.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RGM, included in total RGM listed in Table 1. Distinction between these 2 closely related species was not made. NA: not available; GLP: Guadeloupe; MTQ: Martinique; GUF: French Guiana. Drug-susceptibility patterns were not generalized as mentioned for other species in Tables 1 and 2 (defined as ā¤10% of all isolates displaying in vitro resistance [10]); instead, the results are given per strain (numbers in brackets for more than 2 strains). AMIK: amikacin; CIPRO: ciprofloxacin; CLARIT: clarithromycin; CLOFA: clofazimine; D-CS: D-cycloserine; OFLO: ofloxacin; RBT: rifabutin; RIF: rifampin; SPARFLO: sparfloxacin. Note that drug concentration is mentioned for drugs screened at 2 different concentrations. |